Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Asafetida is a non-standardized food and plant allergenic extract and nitrate vasodilator derived from Ferula species. It is primarily used in clinical allergy testing and has historical applications in traditional medicine for gastrointestinal and respiratory conditions.
Name
Asafetida
Raw Name
ASAFETIDA
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
12
Variant Count
21
Last Verified
February 17, 2026
About Asafetida
Asafetida is a non-standardized food and plant allergenic extract and nitrate vasodilator derived from Ferula species. It is primarily used in clinical allergy testing and has historical applications in traditional medicine for gastrointestinal and respiratory conditions.
Detailed information about Asafetida
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Asafetida.
Asafetida (also known as Hing, Devil's Dung, or Food of the Gods) is an oleo-gum-resin obtained from the exudate of the roots and rhizomes of several species of Ferula, most notably Ferula assa-foetida. In the modern clinical landscape, Asafetida is pharmacologically classified as a Non-Standardized Food Allergenic Extract [EPC], a Non-Standardized Plant Allergenic Extract [EPC], and a Nitrate Vasodilator [EPC]. While it is widely recognized as a culinary spice and a staple in Ayurvedic and Unani traditional medicine systems, its primary role in Western clinical practice involves its use as an allergenic extract for diagnostic testing and its characterized properties as a vasodilator.
As an allergenic extract, Asafetida belongs to a class of drugs used to diagnose or treat IgE-mediated allergic reactions. Because it is 'non-standardized,' the potency of the extract is not measured by a specific biological unit, but rather by the weight/volume ratio of the raw material to the extracting fluid. The FDA has historically regulated these extracts under the Biologics Control Act, ensuring they meet specific safety and purity standards, though they lack the standardized potency units found in more common allergens like ragweed or grass pollen.
The mechanism of action for Asafetida varies significantly depending on its clinical application. When used as an allergenic extract for skin testing, Asafetida works by eliciting a Type I hypersensitivity reaction in sensitized individuals. Upon introduction into the skin (via prick or intradermal methods), the allergenic proteins and compounds in the extract bind to specific IgE antibodies on the surface of mast cells. This binding triggers mast cell degranulation, releasing histamine and other inflammatory mediators, which results in a localized 'wheal and flare' reaction. This allows healthcare providers to confirm a patient's sensitivity to the substance.
From a physiological and vasodilatory perspective, Asafetida contains a complex mixture of volatile oils (rich in sulfur compounds), resins, and gums. The sulfur-containing compounds, particularly organic disulfides, are believed to contribute to its vasodilatory effects. Research suggests that these compounds may facilitate the release of nitric oxide or inhibit calcium influx in smooth muscle cells, leading to a reduction in peripheral vascular resistance. This mechanism aligns with its classification as a nitrate vasodilator, although it is not typically used as a primary treatment for hypertension in modern cardiology.
The pharmacokinetics of Asafetida are complex due to the multi-component nature of the resin. Most data is derived from studies on its individual constituents, such as ferulic acid and various organosulfur compounds.
Asafetida has several clinical and diagnostic applications recognized by healthcare providers:
Asafetida is available in several preparations, depending on the intended use:
> Important: Only your healthcare provider can determine if Asafetida is right for your specific condition. Diagnostic use must be performed under the supervision of a qualified allergist or immunologist.
Dosage for Asafetida varies widely based on the clinical objective and the formulation used. Because it is a non-standardized substance, there is no single 'gold standard' dose.
Specific dosage adjustments for patients with kidney disease have not been established. However, since the metabolites are primarily excreted renally, healthcare providers typically advise caution. In patients with a GFR (Glomerular Filtration Rate) below 30 mL/min, the dose should be reduced by at least 50%, and the patient should be monitored for signs of toxicity.
As the liver is responsible for the conjugation of Asafetida's phenolic constituents, patients with hepatic cirrhosis or acute hepatitis may experience prolonged half-lives of the drug. Use is generally not recommended in severe hepatic impairment (Child-Pugh Class C).
Geriatric patients often have reduced renal clearance and a higher prevalence of polypharmacy. Dosing should start at the lowest end of the spectrum (e.g., 100 mg once daily) to assess tolerance. Monitoring for hypotension is critical in this population due to the drug's vasodilatory properties.
If a dose is missed, it should be taken as soon as remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped. Do not double the dose to catch up, as this increases the risk of hypotension and GI distress.
Signs of Asafetida overdose include:
In the event of a suspected overdose, contact a poison control center immediately. Treatment is primarily supportive, focusing on maintaining blood pressure and, in the case of methemoglobinemia, administering methylene blue if indicated by a physician.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
Asafetida is known for its potent physiological effects, and many users experience mild to moderate side effects, especially when beginning treatment or using high doses.
> Warning: Stop taking Asafetida and call your doctor immediately if you experience any of these.
With prolonged use, Asafetida may lead to chronic digestive changes. There is also a theoretical risk of interference with thyroid function due to certain phytochemicals, though human data is lacking. Long-term use in women may lead to changes in the menstrual cycle (menorrhagia) due to its emmenagogue effects. Patients using Asafetida for more than 30 days should undergo periodic blood pressure and hematological monitoring.
No FDA black box warnings for Asafetida. However, the clinical community maintains a 'de facto' warning regarding its use in infants due to the established risk of life-threatening methemoglobinemia.
Report any unusual symptoms to your healthcare provider. Monitoring of blood oxygen levels (pulse oximetry) may be necessary if shortness of breath occurs.
Asafetida is a potent bioactive substance. Patients must be aware that while it is a natural resin, it possesses significant pharmacological activity that can interfere with standard medical treatments. It should never be used as a substitute for prescribed vasodilators or antihypertensive medications without direct medical supervision.
No FDA black box warnings for Asafetida.
If you are taking Asafetida medicinally for an extended period, your healthcare provider may require the following tests:
Asafetida may cause dizziness or lightheadedness due to its effects on blood pressure. Patients should assess their reaction to the medication before driving or operating heavy machinery. If you feel faint or 'foggy,' avoid these activities and consult your doctor.
Alcohol should be avoided or strictly limited while taking Asafetida. Alcohol is also a vasodilator and a CNS depressant; combining it with Asafetida can lead to additive effects, resulting in severe dizziness, fainting, or significantly impaired coordination.
There is no evidence of a formal withdrawal syndrome associated with Asafetida. However, if used for its vasodilatory or digestive effects, sudden discontinuation may lead to a 'rebound' of symptoms, such as increased blood pressure or severe dyspepsia. It is generally recommended to taper the dose over one week if it has been used daily for more than a month.
> Important: Discuss all your medical conditions, including any history of blood disorders or low blood pressure, with your healthcare provider before starting Asafetida.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication reconciliation is necessary to prevent adverse interactions.
Asafetida must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a physician:
Patients who are allergic to the following substances may also be allergic to Asafetida:
> Important: Your healthcare provider will evaluate your complete medical history, including any underlying genetic conditions like G6PD deficiency, before prescribing or using Asafetida extracts.
Asafetida is strictly contraindicated during pregnancy. Clinical and ethnobotanical data confirm its role as an emmenagogue and abortifacient. It may interfere with the hormonal balance required to maintain a pregnancy and can induce uterine contractions. There is no 'safe' dose of Asafetida during pregnancy. If you become pregnant while taking Asafetida, discontinue use immediately and contact your obstetrician.
Asafetida should be avoided during breastfeeding. The volatile sulfur compounds and other phytochemicals are likely excreted into breast milk, which can give the milk a pungent odor and potentially cause colic or digestive upset in the nursing infant. More importantly, the risk of methemoglobinemia in the infant via breast milk exposure, while not fully quantified, is a serious theoretical concern.
Asafetida is not approved for pediatric use. The risk of methemoglobinemia is the primary concern. In older children, there is a lack of safety data regarding its effects on growth and development. Clinical use of allergenic extracts in children must be performed only by pediatric allergy specialists in a controlled environment equipped for emergency resuscitation.
In patients over 65, Asafetida should be used with extreme caution. This population is more susceptible to the orthostatic hypotension (dizziness upon standing) caused by the drug's vasodilatory effects, which significantly increases the risk of falls and fractures. Furthermore, age-related declines in renal function mean that the drug's metabolites may accumulate, increasing the risk of side effects. Always start with the lowest possible dose in elderly patients.
Patients with impaired kidney function (CrCl < 60 mL/min) require close monitoring. While there are no specific GFR-based dosing tables, a conservative approach is to reduce the frequency of dosing. Asafetida is not known to be cleared by hemodialysis; therefore, patients on dialysis should avoid its use unless the benefits clearly outweigh the risks.
In patients with liver disease, the metabolism of phenolic compounds like ferulic acid is impaired. This can lead to increased systemic exposure. Asafetida should be used cautiously in patients with mild-to-moderate hepatic impairment and avoided entirely in those with severe liver failure or biliary obstruction, as the resin may affect bile flow.
> Important: Special populations require individualized medical assessment. Always consult with a specialist before administering Asafetida to vulnerable groups.
Asafetida acts through several distinct pharmacological pathways:
| Parameter | Value |
|---|---|
| Bioavailability | Estimated 40-60% (for ferulic acid) |
| Protein Binding | 60-75% |
| Half-life | 2-4 hours (major constituents) |
| Tmax | 1-2 hours |
| Metabolism | Hepatic (Glucuronidation/Sulfation) |
| Excretion | Renal (80%), Pulmonary (trace volatile oils) |
Asafetida is categorized as a Non-Standardized Food/Plant Allergenic Extract and a Nitrate Vasodilator. It is related to other Apiaceae extracts used in allergy medicine and shares some physiological characteristics with organic nitrates used in cardiology, although its potency is significantly lower.
Medications containing this ingredient
Common questions about Asafetida
Asafetida is primarily used in clinical settings as a non-standardized allergenic extract to diagnose specific food or plant allergies through skin testing. In traditional and integrative medicine, it is frequently used to treat gastrointestinal issues such as flatulence, irritable bowel syndrome (IBS), and indigestion due to its antispasmodic properties. It is also classified as a nitrate vasodilator, meaning it can help relax blood vessels, although it is not a first-line treatment for heart conditions. Some also use it as an expectorant for respiratory conditions like bronchitis. Always consult a healthcare provider before using it for any medical purpose.
The most common side effects of Asafetida include gastrointestinal upset, such as gas, bloating, and a burning sensation in the stomach. Many people also experience frequent burping with a strong, garlicky odor that can be unpleasant. Because it widens blood vessels, headaches and slight dizziness are also frequently reported, especially at higher doses. In some cases, it may cause diarrhea or a mild skin rash if handled directly. Most of these side effects are dose-dependent and resolve once the substance is discontinued.
It is generally not recommended to consume alcohol while taking medicinal doses of Asafetida. Both alcohol and Asafetida have vasodilatory effects, meaning they widen blood vessels and can lower blood pressure. Combining them can lead to an additive effect, significantly increasing the risk of dizziness, fainting, and lightheadedness. Furthermore, both substances can have a mild sedative effect on the central nervous system, which may impair your coordination and reaction time. If you are using Asafetida, speak with your doctor about whether any alcohol consumption is safe for you.
No, Asafetida is strictly contraindicated and considered unsafe during pregnancy. It has well-documented emmenagogue and abortifacient properties, meaning it can stimulate menstrual flow and induce uterine contractions, which may lead to miscarriage. Historically, it has been used in various cultures to terminate pregnancies, making it a high-risk substance for expectant mothers. There is no known safe level of medicinal Asafetida during any stage of pregnancy. If you are pregnant or planning to become pregnant, you should avoid Asafetida in all medicinal forms.
The onset of action for Asafetida depends on the form and the condition being treated. When used as a digestive aid, many patients report relief from gas or spasms within 30 to 60 minutes after oral ingestion. For diagnostic allergy skin testing, the reaction typically occurs very quickly, with results visible within 15 to 20 minutes. If used for its vasodilatory effects, it may take several days of consistent dosing to notice a change in symptoms. Always follow the specific timeline provided by your healthcare professional.
While Asafetida is not known to be addictive or cause a traditional withdrawal syndrome, you should consult your doctor before stopping it suddenly if you have been using it daily for a long time. Stopping abruptly could cause a return of the symptoms you were treating, such as severe bloating or digestive discomfort. If you were using it for its effects on blood pressure, a sudden stop might cause a slight 'rebound' increase in pressure. A gradual reduction in dose over several days is usually the safest way to discontinue any medicinal supplement. Your doctor can provide a specific tapering schedule if necessary.
If you miss a dose of Asafetida, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at once to make up for the one you missed, as this can increase the risk of side effects like low blood pressure, headache, and stomach irritation. Keeping a consistent schedule helps maintain the effectiveness of the treatment. If you frequently miss doses, consider setting a reminder on your phone or using a pill organizer.
There is currently no clinical evidence to suggest that Asafetida causes weight gain. In fact, because it is often used to improve digestion and reduce bloating, some patients may feel they look 'thinner' due to reduced abdominal distension. It does not contain significant calories, nor does it appear to affect metabolic rate or fat storage in a way that would lead to weight accumulation. If you experience sudden weight gain while taking Asafetida, it is likely due to another factor, such as changes in diet, activity level, or another underlying medical condition, and you should discuss this with your doctor.
Asafetida can interact with several types of medications, so it must be used with caution. It is particularly dangerous when combined with blood thinners like warfarin or aspirin, as it may increase the risk of bleeding. It also interacts with blood pressure medications and nitrates, potentially causing blood pressure to drop too low. Because it may lower blood sugar, patients on diabetes medications need to monitor their levels closely. Always provide your healthcare provider with a full list of all prescriptions, over-the-counter drugs, and herbal supplements you are taking before starting Asafetida.
Asafetida itself is a natural substance and is not 'branded' in the way pharmaceutical drugs are, so it is essentially always available in a 'generic' or unbranded form. You can find it as a raw resin, a powder, or in capsules from various health supplement manufacturers. However, when used as a clinical allergenic extract, it is produced by specific biological laboratories. These extracts are not typically referred to as generics but are sold under the manufacturer's name. Always ensure you are purchasing Asafetida from a reputable source that tests for purity and contaminants.